EMA Withdrawn: Rivastigmine 3M Health Care Ltd (rivastigmine) — 3M Health Care Limited

View source ↗

Summary

EMA withdrew the rivastigmine product from 3M Health Care Limited, with the withdrawn status recorded for Alzheimer disease treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Rivastigmine (Rivastigmine)

Snippet

Status: Withdrawn. Therapeutic area: Alzheimer Disease. MAH: 3M Health Care Limited. Decision date: 19/08/2014